Showing results (81-90 of 236) with videos related to
Sort By:
Pageof 24
AIDS (London, England)|April 15, 2015
Liver-related death among HIV/hepatitis C virus-co-infected individuals: implications for the era of directly acting antiviralsDaniel Grint, Lars Peters, Juergen K Rockstroh, et al.Antiviral Therapy|August 6, 2011
Hyaluronic acid levels predict increased risk of non-AIDS death in hepatitis-coinfected persons interrupting antiretroviral therapy in the SMART Study, Lars Peters, Jacqueline Neuhaus, et al.AIDS (London, England)|January 16, 2008
Comparison of genotypic resistance profiles and virological response between patients starting nevirapine and efavirenz in EuroSIDAWendy P Bannister, Lidia Ruiz, Alessandro Cozzi-Lepri, et al.AIDS (London, England)|April 28, 2011
Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA studyJean-Paul Viard, Jean-Claude Souberbielle, Ole Kirk, et al.Antiviral Therapy|September 28, 2012
The clinical benefits of antiretroviral therapy in severely immunocompromised HIV-1-infected patients with and without complete viral suppressionAmanda Mocroft, Wendy P Bannister, Ole Kirk, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|June 9, 2006
Regional changes over time in initial virologic response rates to combination antiretroviral therapy across EuropeWendy P Bannister, Ole Kirk, Jose M Gatell, et al.Journal of the International AIDS Society|November 14, 2014
Predictive value of prostate-specific antigen for prostate cancer: a nested case-control study in EuroSIDALeah Shepherd, Alvaro Humberto Borges, Lene Ravn, et al.AIDS (London, England)|January 10, 2015
Thrombocytopenia is associated with an increased risk of cancer during treated HIV diseaseÁlvaro H Borges, Jens D Lundgren, Annalisa Ridolfo, et al.AIDS (London, England)|August 28, 2007
Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-scoreAmanda Mocroft, Bruno Ledergerber, Kai Zilmer, et al.AIDS (London, England)|December 24, 2013
Predictors of advanced chronic kidney disease and end-stage renal disease in HIV-positive personsLene Ryom, Amanda Mocroft, Ole Kirk, et al.Pageof 24